Status:
COMPLETED
Pivotal Response Treatment for Children With Autism Spectrum Disorders
Lead Sponsor:
Yale University
Collaborating Sponsors:
National Institute of Neurological Disorders and Stroke (NINDS)
Conditions:
Autism Spectrum Disorders
Eligibility:
All Genders
4-35 years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate the application of an evidence-based, manualized treatment for children with Autism Spectrum Disorder (ASD) (Pivotal Response Treatment, PRT) to children ages ...
Eligibility Criteria
Inclusion
- Participants will:
- Fit the age requirement: age 4-35
- Have been diagnosed previously with an ASD and meet criteria for ASD when characterized by research team.
- Be in good medical health
- Be cooperative with testing
- English is a language spoken in the family
- Successfully complete an fMRI and EEG scan
- Full-scale IQ\>50
Exclusion
Key Trial Info
Start Date :
May 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2020
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT01908686
Start Date
May 1 2012
End Date
March 1 2020
Last Update
August 14 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yale Child Study Center - Autism Program
New Haven, Connecticut, United States, 06512